Annual accounts receivable:
$0.00-$102.00K(-100.00%)Summary
- As of today (September 19, 2025), VRDN annual accounts receivable is $0.00, with the most recent change of -$102.00 thousand (-100.00%) on December 31, 2024.
- During the last 3 years, VRDN annual accounts receivable has fallen by -$451.00 thousand (-100.00%).
- VRDN annual accounts receivable is now -100.00% below its all-time high of $1.46 million, reached on December 31, 2017.
Performance
VRDN Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
N/ASummary
- VRDN quarterly accounts receivable is not available.
Performance
VRDN Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
VRDN Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | - |
| 3 y3 years | -100.0% | - |
| 5 y5 years | -100.0% | - |
VRDN Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | ||
| 5 y | 5-year | -100.0% | at low | ||
| alltime | all time | -100.0% | at low |
VRDN Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2024 | - | $14.00K(>+9900.0%) |
| Jun 2024 | - | $0.00(-100.0%) |
| Mar 2024 | - | $102.00K(0.0%) |
| Dec 2023 | $102.00K(0.0%) | $102.00K(0.0%) |
| Sep 2023 | - | $102.00K(0.0%) |
| Jun 2023 | - | $102.00K(-20.3%) |
| Mar 2023 | - | $128.00K(+25.5%) |
| Dec 2022 | $102.00K(-77.4%) | $102.00K(-85.3%) |
| Jun 2022 | - | $693.00K(+32.8%) |
| Mar 2022 | - | $522.00K(+15.7%) |
| Dec 2021 | $451.00K(+317.6%) | $451.00K(-5.8%) |
| Sep 2021 | - | $479.00K(-76.6%) |
| Jun 2021 | - | $2.05M(+48.4%) |
| Mar 2021 | - | $1.38M(+2324.6%) |
| Sep 2020 | - | $57.00K(-77.0%) |
| Jun 2020 | - | $248.00K(+4860.0%) |
| Mar 2020 | - | $5000.00(-95.4%) |
| Dec 2019 | $108.00K(+350.0%) | $108.00K(-89.0%) |
| Sep 2019 | - | $979.00K(+201.2%) |
| Jun 2019 | - | $325.00K(+5316.7%) |
| Mar 2019 | - | $6000.00(-75.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $24.00K(-98.4%) | $24.00K(-98.3%) |
| Sep 2018 | - | $1.38M(+15.4%) |
| Jun 2018 | - | $1.20M(-75.1%) |
| Mar 2018 | - | $4.81M(+230.3%) |
| Dec 2017 | $1.46M(+7180.0%) | $1.46M(+129.3%) |
| Sep 2017 | - | $635.00K(+17.8%) |
| Jun 2017 | - | $539.00K(+94.6%) |
| Mar 2017 | - | $277.00K(+1285.0%) |
| Dec 2016 | $20.00K(-94.9%) | $20.00K(-97.3%) |
| Sep 2016 | - | $733.00K(+11.4%) |
| Jun 2016 | - | $658.00K(+34.3%) |
| Mar 2016 | - | $490.00K(+24.4%) |
| Dec 2015 | $394.00K(-66.8%) | $394.00K(-28.0%) |
| Sep 2015 | - | $547.00K(-5.9%) |
| Jun 2015 | - | $581.00K(-2.8%) |
| Mar 2015 | - | $598.00K(-49.7%) |
| Dec 2014 | $1.19M(+19.5%) | $1.19M(-23.4%) |
| Sep 2014 | - | $1.55M(+14.0%) |
| Jun 2014 | - | $1.36M(+36.8%) |
| Dec 2013 | $994.00K(-16.9%) | $994.00K(-16.9%) |
| Dec 2012 | $1.20M | - |
| Dec 2012 | - | $1.20M |
FAQ
- What is Viridian Therapeutics, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual accounts receivable year-on-year change?
- What is the all time high quarterly accounts receivable for Viridian Therapeutics, Inc.?
What is Viridian Therapeutics, Inc. annual accounts receivable?
The current annual accounts receivable of VRDN is $0.00
What is the all time high annual accounts receivable for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual accounts receivable is $1.46M
What is Viridian Therapeutics, Inc. annual accounts receivable year-on-year change?
Over the past year, VRDN annual accounts receivable has changed by -$102.00K (-100.00%)
What is the all time high quarterly accounts receivable for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly accounts receivable is $4.81M